Lupin Pharmaceuticals Inc. recalls
12 notices naming Lupin Pharmaceuticals Inc. as the recalling firm, since November 27, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Lupin Pharmaceuticals Inc.: Clobetasol Propionate Cream USP
Hazard (FDA): Failed content uniformity specifications.
FDAMedicines
Lupin Pharmaceuticals Inc.: Glucagon Emergency Kit for Low Blood Sugar
Hazard (FDA): CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
FDAMedicines
Lupin Pharmaceuticals Inc.: prednisoLONE Acetate Ophthalmic Suspension
Hazard (FDA): Presence of Foreign Substance
FDAMedicines
Lupin Pharmaceuticals Inc.: Liraglutide Injection
Hazard (FDA): Presence of particulate matter: a white thread-like structure in the cartridge
FDAMedicines
Lupin Pharmaceuticals Inc.: Ganirelix Acetate Injection
Hazard (FDA): Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
FDAMedicines
Lupin Pharmaceuticals Inc.: Sertraline Hydrochloride Tablets USP
Hazard (FDA): Defective container - seal not adhering to bottles
FDAMedicines
Lupin Pharmaceuticals Inc.: Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg
Hazard (FDA): Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
FDAMedicines
Lupin Pharmaceuticals Inc.: clomiPRAMINE Hydrochloride Capsules USP 25 mg
Hazard (FDA): Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
FDAMedicines
Lupin Pharmaceuticals Inc.: Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg
Hazard (FDA): Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir…
FDAMedicines
Lupin Pharmaceuticals Inc.: clomiPRAMINE hydrochloride Capsules USP
Hazard (FDA): Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.
FDAMedicines
Lupin Pharmaceuticals Inc.: Levothyroxine Sodium Tablets
Hazard (FDA): Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
FDAMedicines
Lupin Pharmaceuticals Inc.: Ramipril Capsules USP 2.5 mg and 2 more
Hazard (FDA): CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
FDAMedicines